This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, I.
Right arrow Articles by Pizza, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, I.
Right arrow Articles by Pizza, M.

 Previous Article  |  Next Article 

Infect Immun, April 1998, p. 1648-1653, Vol. 66, No. 4
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

A Recombinant Live Attenuated Strain of Vibrio cholerae Induces Immunity against Tetanus Toxin and Bordetella pertussis Tracheal Colonization Factor

Inês Chen,1,2 Theresa M. Finn,3 Liu Yanqing,4 Qi Guoming,4 Rino Rappuoli,1,* and Mariagrazia Pizza1

IRIS, Chiron Vaccines Immunobiological Research Institute in Siena, 53100 Siena, Italy1; Departamento de Microbiologia, ICB II, Universidade de São Paulo, São Paulo, SP 05508-900, Brazil2; Laboratory of Pertussis, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892-00293; and Chinese Academy of Preventive Medicine, Beijing, China4

Received 2 September 1997/Returned for modification 25 October 1997/Accepted 7 December 1997

An attenuated strain of Vibrio cholerae was used as a carrier for the expression of heterologous antigens such as fragment C from tetanus toxin (TetC) and tracheal colonization factor from Bordetella pertussis (Tcf). In vitro, high levels of protein were obtained when the Escherichia coli nirB promoter was used and the bacteria were grown with low aeration. Intranasal immunization of mice with IEM101 expressing TetC elicited serum vibriocidal activity and induced antibodies against tetanus toxin which were protective against lethal challenge with 10 times the 50% lethal dose of tetanus toxin. Bacterial viability was essential for the induction of anti-TetC antibodies. Intranasal administration of IEM101 expressing Tcf induced a significant reduction in bacterial colonization of the tracheas of mice challenged with wild-type B. pertussis. These data are in agreement with the putative role of Tcf in Bordetella tracheal colonization. In conclusion, we have demonstrated that V. cholerae may be used as a live vector to deliver heterologous antigens in vivo and that protection to both systemic and local challenge may be achieved.


* Corresponding author. Mailing address: IRIS, Chiron Vaccines Immunobiological Research Institute in Siena, Via Fiorentina, 1, 53100 Siena, Italy. Phone: 39-577-243414. Fax: 39-577-243564. E-mail: Rappuoli{at}IRIS02.BIOCINE.IT.




This article has been cited by other articles:

  • Brossier, F., Weber-Levy, M., Mock, M., Sirard, J.-C. (2000). Protective Antigen-Mediated Antibody Response against a Heterologous Protein Produced In Vivo by Bacillus anthracis. Infect. Immun. 68: 5731-5734 [Abstract] [Full Text]  
  • Mesnage, S., Weber-Levy, M., Haustant, M., Mock, M., Fouet, A. (1999). Cell Surface-Exposed Tetanus Toxin Fragment C Produced by Recombinant Bacillus anthracis Protects against Tetanus Toxin. Infect. Immun. 67: 4847-4850 [Abstract] [Full Text]  
  • Ryan, E. T., Crean, T. I., John, M., Butterton, J. R., Clements, J. D., Calderwood, S. B. (1999). In Vivo Expression and Immunoadjuvancy of a Mutant of Heat-Labile Enterotoxin of Escherichia coli in Vaccine and Vector Strains of Vibrio cholerae. Infect. Immun. 67: 1694-1701 [Abstract] [Full Text]